CONNECT WITH US
eCommerce

eCommerce

Solabia Refocuses on Cosmetics and Nutraceuticals as Muriel Koch Takes CEO Role

Global Cosmetics News logo

Published on

Add as a preferred source on Google
Solabia Refocuses on Cosmetics and Nutraceuticals as Muriel Koch Takes CEO Role

THE WHAT? Astorg-owned ingredients manufacturer Solabia has announced a strategic restructuring to strengthen its position in cosmetics, nutraceuticals and biotechnology, alongside the appointment of Muriel Koch as President and Chief Executive Officer.

THE DETAILS Solabia plans to divest its microbiology diagnostics division to Oxoid Remel Microbiology, another Astorg portfolio company, subject to regulatory approvals and definitive agreements. The move follows its acquisition of Mibelle Biochemistry in June 2026, strengthening its position in cosmetic active ingredients. Muriel Koch, formerly CEO of Groupe NUXE, will take over on 29 October 2026, succeeding Jean-Baptiste Dellon, who led the company for four and a half years. The restructuring will concentrate resources on natural and biotechnology-derived active ingredients while supporting international expansion.

THE WHY? The strategic repositioning reflects growing investment in science-backed cosmetic ingredients and the consolidation of specialist suppliers. By concentrating on its core markets and strengthening its leadership, Solabia aims to accelerate innovation, expand its international presence and reinforce its position within the global beauty ingredients industry.



Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.